Covid-19: Innova lateral flow test is not fit for “test and release” strategy, say experts
BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4469 (Published 17 November 2020) Cite this as: BMJ 2020;371:m4469Read our latest coverage of the coronavirus outbreak
- Elisabeth Mahase
- The BMJ
The government has claimed that rapid lateral flow covid-19 tests, which are being used in mass testing pilots in England and can provide results in 30 minutes, are “accurate and sensitive enough to be used in the community,” after evaluation results were published.1
However, experts warn that the tests may miss as many as half of covid-19 cases, depending on who is using them—making them unsuitable for a “test and release” strategy to enable people to leave lockdown or to allow students to go home from university.
The ongoing assessment, carried out by Public Health England’s Porton Down laboratory and the University of Oxford, tested a number of lateral flow devices in different settings including hospitals, schools, and universities.
The Innova SARS-CoV-2 Antigen Rapid Qualitative Test, which has been used in the Liverpool mass testing pilot to detect infections,2 is the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.